Related Experiment Video

Updated: Dec 2, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.3K

Cardiovascular Manifestations of COVID-19

Sneha Nandy1, Siu-Hin Wan1, Jorge Brenes-Salazar1

  • 1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, United States.

Current Cardiology Reviews
|November 4, 2020
PubMed

Insights

This review examines the cardiovascular effects of COVID-19, a respiratory illness caused by SARS-CoV-2. It highlights how pre-existing heart conditions impact COVID-19 outcomes and details new cardiac complications arising from the infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to a global health crisis.
  • COVID-19 primarily manifests as a respiratory illness, ranging from mild symptoms to severe pneumonia and ARDS.
  • Patients with cardiovascular risk factors are at increased risk and may experience worsened conditions.

Purpose of the Study:

  • To review the cardiovascular manifestations of COVID-19 reported in the literature.
  • To outline the impact of pre-existing cardiovascular disease on COVID-19 clinical course and outcomes.
  • To detail de novo cardiac complications associated with COVID-19 infection.

Main Methods:

  • Literature review of published studies on COVID-19 and cardiovascular manifestations.
  • Analysis of reported cases detailing cardiac complications.
  • Examination of the influence of cardiovascular risk factors on COVID-19 prognosis.

Main Results:

  • COVID-19 infection can lead to de novo cardiac complications, including myocardial injury and arrhythmias.
  • Pre-existing cardiovascular disease and risk factors are associated with increased susceptibility and poorer outcomes in COVID-19 patients.
  • The review synthesizes current knowledge on the multifaceted cardiovascular impact of SARS-CoV-2.

Conclusions:

  • COVID-19 presents significant cardiovascular challenges beyond its respiratory effects.
  • Understanding these cardiovascular manifestations is crucial for managing COVID-19 patients, particularly those with underlying heart conditions.
  • Further research is needed to fully elucidate the long-term cardiovascular consequences of SARS-CoV-2 infection.

Keywords:
COVID-19SARS-CoV-2cardiaccardiovascularcoronavirusinfection.

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
200
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
254
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
222
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
233
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
250
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
129